Calidi Biotherapeutics In... (CLDI)
AMEX: CLDI
· Real-Time Price · USD
5.28
0.24 (4.76%)
At close: Aug 15, 2025, 3:59 PM
5.24
-0.76%
After-hours: Aug 15, 2025, 07:55 PM EDT
Calidi Biotherapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
PE Ratio | -0.35 | -0.77 | -0.56 | -0.44 | -0.44 | -0.68 | -1.55 | -5.85 | -2.06 | -3.91 | -3.23 | -12.13 | 17.10 | 48.42 | -20.13 | -85.04 | -7K |
PEG Ratio | 0.03 | 0.11 | 0.01 | 0.01 | 0.01 | 0.06 | -0.02 | 0.09 | -0.02 | 0.28 | 0.00 | 0.14 | 0.09 | -0.74 | 0.03 | -0.01 | n/a |
PS Ratio | n/a | n/a | 6.10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 4.50 | 2.20 | 5.98 | -0.86 | -0.87 | -1.34 | -6.19 | -43.32 | 3.30 | 2.88 | 2.69 | 8.18 | 1.29 | 1.31 | 1.30 | 1.33 | -4.8K |
P/FCF Ratio | n/a | n/a | n/a | n/a | n/a | -5.1 | -9.69 | -2.07 | 1.37K | 1.83K | 99.65 | -649.35 | -1.06K | -608.86 | 555.77 | -190.57 | n/a |
P/OCF Ratio | n/a | n/a | n/a | n/a | n/a | -5.11 | -9.82 | -2.12 | 270.53 | 525.47 | 85.88 | -779.89 | -1.06K | -608.86 | 555.77 | -190.57 | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 1.93 | 0.68 | 4.59 | -0.88 | -0.74 | -0.8 | -0.88 | -8.91 | 0.05 | 0.04 | 0.03 | 0.01 | n/a | n/a | n/a | n/a | -3.24 |
Quick Ratio | 1.13 | 2.12 | 1.08 | 0.19 | 0.12 | 0.13 | 0.42 | 1.07 | 0.10 | 0.04 | 0.09 | 0.36 | 2.03 | 2.67 | 3.61 | 41.86 | 0.17 |
Current Ratio | 1.13 | 2.12 | 1.08 | 0.19 | 0.12 | 0.13 | 0.42 | 1.07 | 0.10 | 0.04 | 0.09 | 0.36 | 2.03 | 2.67 | 3.61 | 41.86 | 0.17 |
Asset Turnover | n/a | n/a | 0.11 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -108.92 | -70.31 | -23.01 | -22.53 | -21.14 | -26.69 | -44.23 | -22.29 | -4.89 | -9.35 | -27.7 | -36.7 | n/a | n/a | -9.73 | n/a | n/a |
Return on Equity | -3.24 | -0.72 | -2.67 | 0.49 | 0.49 | 0.50 | 1.00 | 1.85 | -0.4 | -0.18 | -0.21 | -0.17 | 0.02 | 0.01 | -0.02 | n/a | 0.17 |
Return on Assets | -0.61 | -0.33 | -0.29 | -0.76 | -0.9 | -0.98 | -0.82 | -0.11 | -0.28 | -0.15 | -0.18 | -0.13 | 0.02 | 0.01 | -0.02 | n/a | -0.02 |
Return on Invested Capital | -0.92 | -0.42 | -0.44 | 8.71 | 2.36 | 3.12 | -5.74 | -0.6 | -0.04 | -0.05 | -0.07 | -0.02 | n/a | n/a | n/a | n/a | -0.08 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 0.50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | -2.72 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | -2.76 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | -2.68 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | -2.38 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |